tiprankstipranks
Trending News
More News >
Tango Therapeutics (TNGX)
NASDAQ:TNGX
US Market

Tango Therapeutics (TNGX) Income Statement

Compare
426 Followers

Tango Therapeutics Income Statement

Last quarter (Q3 2025), Tango Therapeutics's total revenue was $53.81M, an increase of 363.61% from the same quarter last year. In Q3, Tango Therapeutics's net income was $15.88M. See Tango Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 42.07M$ 36.53M$ 24.86M$ 37.04M$ 7.66M
Gross Profit
$ 42.07M$ 36.53M$ 24.86M$ 37.04M$ 6.03M
Operating Expenses
$ 187.66M$ 150.70M$ 135.93M$ 95.23M$ 58.23M
Depreciation and Amortization
$ 2.50M$ 2.42M$ 1.61M$ 897.00K$ 1.63M
EBITDA
$ -143.10M$ -111.76M$ -109.46M$ -57.29M$ -50.35M
Operating Income
$ -145.59M$ -114.17M$ -111.07M$ -58.19M$ -52.20M
Other Income/Expenses
$ 15.50M$ 12.56M$ 2.95M$ 247.00K$ 228.00K
Pretax Income
$ -130.09M$ -101.61M$ -108.12M$ -57.94M$ -51.97M
Net Income
$ -130.30M$ -101.74M$ -108.18M$ -58.23M$ -51.97M
Per Share Metrics
Basic EPS
$ -1.19$ -1.08$ -1.23$ -0.94$ -1.62
Diluted EPS
$ -1.19$ -1.08$ -1.23$ -0.94$ -1.62
Weighted Average Shares Outstanding
109.23M 94.57M 87.82M 62.11M 87.47M
Weighted Average Shares Outstanding (Diluted)
109.23M 94.57M 87.82M 62.11M 87.47M
Currency in USD

Tango Therapeutics Earnings and Revenue History